
|Articles|July 24, 2017
Reagan-Udall Foundation for FDA Launches Navigator Website
Advertisement
Reagan-Udall Foundation, the non-profit foundation for the FDA, launched a new website called Expanded Access Navigator. It features a pharma company directory of expanded access policies and criteria, along with educational resources, guides, and downloadable forms.
The American Cancer Society, the American Society of Clinical Oncology, the Biotechnology Industry Association, FDA, Foundation Medicine, PhRMA and Susan G. Komen helped develop the Navigator along with the support of Bristol-Meyers Squibb, Genentech, Janssen, Lilly, Merck and Pfizer.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
ACT Brief: Cross-Asset Site Partnerships, Vaccine Trial Standardization, and Ovarian Cancer Care Gaps
3
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
4
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
5



